PHarma Talks


PHarma Talks: Panel: Accelerating research with emerging information technologiesAccelerating Research with Emerging Information Technologies

Date and Time

Day                 Tuesday, June 22, 2021

Time                1:00 pm EDT (10:00 am PT)

Duration          60 minutes

Location          Webinar


Michael Iarrobino: Copyright Clearance Center, Director Product Management

Yiannis Kiachopoulos: Causaly, Co-founder and CEO

Josh Nicholson, PhD:, Chief Executive Officer


Lauren Tulloch: Copyright Clearance Center, Vice President and Managing Director


Emerging technologies present exciting new opportunities for information professionals to help researchers turn scientific content and data into insights to accelerate innovation.

Join expert panelists from Copyright Clearance Center, Causaly and for a lively discussion on new information management tools and the benefits they provide for R&D intensive organizations. Topics will include semantic enrichment, AI and machine learning, knowledge graphs, and citation metrics. You’ll walk away from this panel with tips and strategies to increase your return on content investments and better equip researchers to solve today’s challenges.

return to top

PHarma talks: Building a Publication Knowledge Graph with Artificial Intelligence for Drug Discovery

Day                 Tuesday, May 18, 2021

Time                2:00 pm EDT (11:00 am PT)

Duration          60 minutes

Location          Webinar


Please register by clicking this link.

There is no cost for attendees of this event.


Sean Grullon – Lead AI Scientist, Proscia

Sean Grullon is the Lead AI Scientist at Proscia, whose mission is to perfect cancer diagnosis with software and artificial intelligence algorithms. Sean has nearly seven years of experience in Artificial Intelligence work in Health Care and the Life Sciences, including working at IBM Watson Health and the GSK AI Research organization. Prior to a career switch to working as an AI scientist in health care, Sean was a particle physics researcher at the University of Pennsylvania and received his Ph.D from the University of Wisconsin - Madison.  

return to top

PHarma talks: Demystifying Systematic Literature Reviews: Identifying Opportunities for Information Teams and Librarians

By Meaghan Muir, Information Manager, Vertex Pharmaceuticals Inc.

Date and Time

Day                 Thursday, April 22, 2021

Time                2:00 pm EDT (11:00 am PT)

Duration          60 minutes

Location          Webinar

About this Event

This session will introduce participants to the primary concepts, methodologies, and processes involved in systematic reviews and demonstrate the exciting cross-functional opportunities they represent to Information Teams and Librarians.  Key takeaways:

  • What is a systematic review?
    • Methodology and process
  • Best practices for systematic review searches

Collaborating on systematic reviews within your organization

Intended Audience:

All levels; no previous systematic literature searching experience required




Meaghan Muir – Information Manager, Vertex Pharmaceuticals, Inc.

Meaghan Muir joined the Library & Information Sciences team at Vertex Pharmaceuticals in November 2018 as Information Manager.  She is responsible for scientific intelligence searching, as well as supporting library training and marketing activities across Vertex. Prior to joining Vertex, Meaghan was the Manager of Library Services at Boston Children’s Hospital where she led a team of librarians and archivists and oversaw the medical library and archives program. Meaghan has also worked in medical libraries at Brigham and Women’s Hospital and Spaulding Rehabilitation Hospital, both in Boston. Meaghan has extensive experience conducting, designing, and teaching systematic literature review searches; her work has earned her numerous co-authorships and published acknowledgement.


 return to top




PHarmaTalks: "Building visualizations to uncover insights in clinical trial and pipeline data: a COVID-19 vaccine case study"

By Matt Eberle, Lead Developer, Analytics and Custom Solutions, & Diane Webb, President and Co-Founder of BizInt Solutions, Inc.

Date and Time

Day                 Wednesday, March 31, 2021

Time                2:00 pm EDT (11:00 am PT)

Duration          60 minutes

Location          Webinar

About this Event

Interested in learning how clinical trial and drug pipeline visualizations can offer insights into the drug development landscape?  Join Diane Webb and Matt Eberle for a discussion of techniques used and lessons learned from a project to track COVID-19 vaccine progress starting in the summer of 2020.   We will discuss how trial timeline and bullseye visualizations were created and then updated bi-weekly, and how "real-world" developments were incorporated in the fall.  We will discuss the differences in using clinical trial and pipeline data, search strategies, and the different ways that pipeline databases indexed phase, technology and company information for COVID-19 vaccines.  The presentation will conclude with lessons learned and recommendations for building visualizations and dashboards.

Key Takeaways:

  1. Types of visualizations useful for displaying drug landscapes using clinical trial and drug pipeline data.
  2. What to consider at the beginning of your visualization/dashboard project, and revisiting your decisions over time.
  3. How the treatment of COVID-19 vaccines in clinical trial and drug pipeline databases evolved during the pandemic.


Matt Eberle, Lead Developer, Analytics and Custom Solutions, BizInt Solutions, Inc.

Following over ten years of experience at Wyeth, Pfizer and Sunovion as a Senior Information Scientist and Pharmaceutical Information Analyst, since 2013 Matt has helped BizInt customers use the BizInt Smart Charts and VantagePoint tools to create new solutions to address their challenges and problems.  Matt lives outside Boston, MA.

Diane Webb, President and Co-Founder, BizInt Solutions, Inc.

Diane has over 30 years of experience managing the development of software tools to analyze and present competitive intelligence information, with a focus on drug pipeline, clinical trial and patent data. In 1996 Diane and John Willmore started BizInt Solutions to develop and market the BizInt Smart Charts product family. Diane & John live near Seattle, WA, with their current pack of four longhaired dachshunds.


Presented by

Pharmaceutical & Health Technology Community


Interested in SLA membership? Click here for information.

return to top

PHarma Talks: “Transforming Data into Knowledge Using Power BI" by Chrissy Geluk, CEO of Librarian At Your Service

Thu, Feb 25, 2021 2:00 PM - 3:00 PM EST


Please register by clicking this linkThere is no cost for attendees of this event.


About this Event

The session will focus on leveraging Power BI®  (Microsoft Business Intelligence software) on how to tell “THAT” story. That story refers to delivering actionable results from a search or analysis, that helps the reader understand the data and what it means to them. Examples of data that can be transformed are: usage metrics, company research, patent search results, and more!

The session is structured for both new users to Power BI and those that may be using Power BI (or even Tableau) on a regular basis. It will begin with an initial overview of Power BI (datasets, reports and its pages, and dashboards) and building the visuals to tell the story you need. While the focus is on Power BI and building a final deliverable, there will be some discussion on other "intelligence tools" and how to share the deliverable that fits within your organization. A true example will drive the anatomy of Power BI and its deliverable; and with a prayer to the demo gods, a Power BI deliverable will (hopefully) be built from raw data live using the tips learned throughout the session.

Some Key Takeaways

  • Understanding between Power BI datasets, reports and dashboards
  • Appreciation of the available "tools" to shape & transform your data into knowledge
  • Exploration of how Power BI interacts with the rest of the Power Platform & M365 families


Chrissy Geluk, CEO, Principal, and Founder of Librarian At Your Service LLC.

Christine was first introduced to SharePoint over 10 years ago when she migrated the corporate library site using SharePoint 2010 Foundation. Since then, Chrissy has continued to learn and apply other Microsoft O365/M365 apps like Power BI in order to help her clients achieve their ultimate business goals. 

Christine launched her own information services business providing literature searches and analyses, content management and development, and end-user training in 2015 after more than 20 years with a multinational pharmaceutical company.

Chrissy earned her undergraduate degree in mathematics from Fordham (Go RAMS!), and her graduate degree in information science from Simmons. Chrissy has also held numerous volunteer leadership positions with SLA, PIUG and AIIP including PHT Chair in 2008. Connect with Chrissy via her website at

return to top

PHarma Talks: "Growing the Information Center – A Case Study," Kimberly Flanagan-Bouchard

Tue, Jan 26, 2021 2:00 PM - 3:00 PM EST

About this Event

Corporate libraries provide a wealth of information and critical services for their companies, supporting bottom-line revenue. They are often overlooked, undervalued, and ultimately eliminated as 'the cost center that just spends too much money."  It's either in their absence or during decisive times (e.g., FDA submissions) that the company feels the gap. In talking about her experience at Daiichi Sankyo, Kimberly will explain how she helped leadership understand the value the library brings, avoid that 'gap,' and why the library could no longer operate on "bubble gum and rubber bands" if the company wanted to accomplish its mission.


Kimberly A. Flanagan-Bouchard, Associate Director, Competitive Intelligence & Library Services, Daiichi Sankyo, Inc.

Kimberly A. Flanagan-Bouchard has worked in the pharmaceutical industry for over 25 years as an information professional.  In 2014, she started as a contractor in the Scientific Library of Daiichi Sankyo, and advanced to Associate Director to manage the strategic vision of the Competitive Intelligence & Library Services, spearheading a globalization effort to support a growing employee base worldwide.  Previously, Kimberly was with Johnson & Johnson, where she developed an Pinnacle Award-winning global information service for the quality & compliance organization, and was Chair of J&J's global information professional group.

Kimberly lives in Sayreville, NJ with her husband Michael and their three teenage boys. She is an avid reader, loves music, gardening, animals and good wine, and takes great pride in being a mom to her sons.  She is an advocate for life-long learning, and not taking life too seriously. You'll always find her laughing, watching Golden Girl re-runs, and speaking in fluid movie quotes.

Write up

View Susie Corbett's write up of Kimberly's talk on SLA Connect

return to top


Wed, November 11th, 2020

The Pharmaceutical & Health Technology Community's webinar series kicked off on November 11, 2020 with a keynote presentation from Doug Long of IQVIA.


As anyone who has previously attended a talk given by Doug Long would know, a LOT of territory was covered within 60 minutes in the first of the PHarma Talks series.  US Pharmaceutical Trends, Issues and Outlook covered both the impact on the industry within the first 100 days of the COVID-19 pandemic, plus some views on the lasting trends that we may see in 2021 and beyond.  As the Vice President, Industry Relations at IQVIA, Doug (pictured) always brings considerable insight and abundant data to his talks and is therefore difficult to summarize in full.  One main theme that emerged however was how COVID-19 has ramped up the use of digital technologies in a variety of points in the healthcare landscape:

  • R&D clinical trials – remote monitoring, digitization of study procedures, digital engagement with patients
  • Pharmaceutical sales – remote detailing and virtual meetings/conferences
  • Healthcare provision – telehealth, remote monitoring, digital therapeutics

R&D Clinical Trials

Though digital enabled changes had already started to be seen in clinical trials, COVID-19 has sped up the process.  This includes the further evolution of remote patient data collection including ePRO (electronic patient-reported outcomes), spirometry, ocular exams, ECGs, glucose monitoring and oximetry.   There has also been an increase in the use of digital communication to keep patients informed and engaged.  Both of these trends reduce the burden on the patient and may therefore increase retention.  And it seems quite likely that these changes have come to stay.

Pharmaceutical Sales

To dive deeper into the changes to pharmaceutical sales, consider that there has been a 500% increase in remote detailing, though 25% of pharma are still not satisfied the quality of remote detailing – gaps remain in coupon, sampling and patient education.  Though in-person engagements have crept back up from the crash of Mar/Apr, as of June it was still only 30% of baseline.  Currently the limitations on in-person detailing are still largely in place and so pharma must continue to "make-do" with remote offerings.  But it will be interesting to see how this trend will continue in the future.  The expectation is there will be a return to some in-person promotions as they can be more effective – note the gaps mentioned previously. But pharmas are likely to also want to continue with the cheaper, more efficient remote approach.  There will be struggle as pharmas try to find the right balance.

Healthcare Provision

Looking at healthcare provision, telehealth is the big trend here – basically non-existent at the beginning of the year, it jumped significantly once COVID-19 hit and has remained steady since then.  The change to reimburse at the same rate for a telehealth visit as for an in-person visit helped foster rise along with the waiving of cost sharing and the expansion of approved technologies.  Telehealth has continued at the same rate, including through the summer months where some areas saw an improved situation.  The continuation of the trend would seem to be a given, but there are factors that might drive it back down such as patient demographics – older and/or poorer patients don't necessarily have the equipment or skill to make telehealth effectual.

Another trend Doug noted that might tie in with the remote detailing and increase in telehealth is a decrease in the prescribing of new drugs.  IQVIA data shows the extent of the effect varies by specialty, with a 17% drop in New to Brand prescriptions by Allergists, all the way up to a 44% drop by Endocrinologists.  New to Therapy patients show the same trends.  The potential drivers are many: the switch to remote detailing; the increase of telehealth visits; fewer new patients; and/or lack of diagnostics.  Which of these is the main driver?  Time will (perhaps) tell.

These are just a few of the topics mentioned in Doug's talk – there was also threats to supply chain, changes to payer mix, growth of specialty drugs outpacing traditional, and more.    There was undoubtedly something (if not multiple things) that provided food for thought for all 73 attendees of the webinar.  It can be easily recommend that you keep an eye out for future talks by Doug – he will be invited back!

 return to top